August 25, 2010 - A privately held medical device company has secured $20 million in Series C financing led by new investor Siemens Venture Capital (SVC) GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors. ViewRay Inc., will use the funding to move the ViewRay system, a unique image-guided radiation therapy system now in the late stages of development, through the process of commercialization and into major medical centers.
The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of simultaneous magnetic resonance imaging (MRI) and radiotherapy delivery.
The ViewRay system currently is only for nonclinical research use. The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis will soon become the first in the world to test the ViewRay system.
For more information: www.viewray.com
April 10, 2026 
